Sex Differences in Chronic Kidney Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03771703|
Recruitment Status : Active, not recruiting
First Posted : December 11, 2018
Last Update Posted : December 11, 2018
Objectives This study aims to describe sex specific differences of the hemodialysis population in Austria, to quantify sex specific differences in treatment and outcomes in hospitalized patients with chronic kidney disease and to examine decision making by doctors and patients with regards to hemodialysis initiation.
To adequately serve the needs of these research questions, the study is divided into 3 parts (sub-studies).
- Description and analysis of sex-specific differences in hemodialysis patients and the associated male-to-female mortality in Austria.
- Description and analysis of sex-specific differences in treatment and outcomes in hospitalized patients with chronic kidney disease.
- Descriptive analysis of decision-making by doctors and patients with regard to hemodialysis initiation.
|Condition or disease|
|Chronic Kidney Diseases|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||30000 participants|
|Official Title:||An Exploratory Study in Three Parts to Determine Sex-Specific Differences in Chronic Kidney Disease Recognition, Progression and Treatment|
|Actual Study Start Date :||December 2, 2018|
|Estimated Primary Completion Date :||April 1, 2022|
|Estimated Study Completion Date :||April 1, 2022|
- Sex-specific mortality among incident patients undergoing hemodialysis [ Time Frame: Through study completion, the expected average follow-up being 4 years. ]"Incident" hemodialysis patients are all those who have entered the Dialysis Registry (they will constitute the study population).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03771703
|Medical University of Vienna|
|Vienna, Austria, 1090|
|Study Director:||Rainer Oberbauer, MD||Medical University of Vienna|